RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
RSV shot for moms shields newborns? massive brazil trial launches.
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests how well an RSV vaccine given to pregnant women works in the real world to protect their babies from serious RSV lung infections. Researchers will follow 5,000 infants in Brazil, comparing those whose mothers got the vaccine to those who didn't. The goal is to se…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Inova Medical • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:05 UTC
-
New RSV vaccine trial aims to protect women from respiratory virus
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests a new vaccine (MKK900) against respiratory syncytial virus (RSV) in 120 healthy women aged 18-49. The goal is to check if the vaccine is safe and triggers a strong immune response. Participants will be monitored for side effects and their antibody lev…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:47 UTC
-
New pill could help babies breathe easier from RSV
Disease control Not yet recruitingThis study tests a new oral drug called zelicapavir in children aged 28 days to 36 months who have RSV infection. The drug aims to stop the virus from multiplying and help symptoms clear faster. About 150 children will participate, and the study compares the drug to a placebo to …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New RSV shot for babies enters early safety testing
Prevention Not yet recruitingThis study tests a new injection called SIBP-A16 to see if it is safe and how the body processes it in premature and full-term infants under 1 year old. The goal is to find the right dose to help prevent RSV, a common and serious lung infection. About 36 infants will take part in…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated May 17, 2026 05:47 UTC